Skip to main content

Advertisement

Log in

Three-year outcomes of transanal total mesorectal excision versus standard laparoscopic total mesorectal excision for mid and low rectal cancer

  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Introduction

Since transanal total mesorectal excision (taTME) was introduced, it has become an important topic in rectal cancer treatment. Many previous studies reported positive relevant short-term results, histopathological results, and associated complications. Recently, concerns regarding the oncological safety of taTME have been raised due to reports showing high local recurrences (LR) rates. Therefore, this study aimed to compare the 3-year outcomes between taTME and laparoscopic total mesorectal excision (laTME) for mid-low rectal cancer.

Methods

A total of 104 patients who underwent taTME were matched with 208 patients treated by laTME. The primary endpoint was 3-year LR rate; secondary endpoints in this matched-cohort study included the perioperative outcomes and histopathological outcomes.

Results

taTME was associated with lower permanent ostomy rate (1% vs 13.5%) and lower conversion rate (0% vs 3.4%) compared to laTME. A similar quality of resected specimens was detected for each group. In both groups, the local recurrence rate was 3.8%. Within 3 years after surgery, the disease-free survival (DFS) rates were 78.8% in the taTME group and 76.9% in the laTME group (P = 0.640), while the overall survival (OS) rates were 93.3% in the taTME group and 89.9% in the laTME group (P = 0.327).

Conclusion

No significant differences regarding 3-year local recurrence rate (3.8%) were observed in the taTME group compared to laTME group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424

    Article  Google Scholar 

  2. Wanqing C, He L, Kexin S, Rongshou Z, Siwei Z, Hongmei Z, Xiaonong Z, Xiuying G, Jie H (2018) Report of cancer incidence and mortality in China, 2014. Chin J Oncol 40:5–13

    Google Scholar 

  3. Heald RJ, Ryall RD (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1:1479–1482

    Article  CAS  Google Scholar 

  4. MacFarlane JK, Ryall RD, Heald RJ (1993) Mesorectal excision for rectal cancer. Lancet 341:457–460

    Article  CAS  Google Scholar 

  5. Gosens MJ, Klaassen RA, Tan-Go I, Rutten HJ, Martijn H, van den Brule AJ, Nieuwenhuijzen GA, van Krieken JH, Nagtegaal ID (2007) Circumferential margin involvement is the crucial prognostic factor after multimodality treatment in patients with locally advanced rectal carcinoma. Clin Cancer Res 13:6617–6623

    Article  CAS  Google Scholar 

  6. Nagtegaal ID, van de Velde CJ, van der Worp E, Kapiteijn E, Quirke P, van Krieken JH (2002) Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 20:1729–1734

    Article  Google Scholar 

  7. Quirke P, Durdey P, Dixon MF, Williams NS (1986) Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 2:996–999

    Article  CAS  Google Scholar 

  8. Bonjer HJ, Deijen CL, Abis GA, Cuesta MA, van der Pas MH, de Lange-de Klerk ES, Lacy AM, Bemelman WA, Andersson J, Angenete E, Rosenberg J, Fuerst A, Haglind E, Group CIS (2015) A randomized trial of laparoscopic versus open surgery for rectal cancer. N Engl J Med 372:1324–1332

    Article  CAS  Google Scholar 

  9. Fleshman J, Branda ME, Sargent DJ, Boller AM, George VV, Abbas MA, Peters WR Jr, Maun DC, Chang GJ, Herline A, Fichera A, Mutch MG, Wexner SD, Whiteford MH, Marks J, Birnbaum E, Margolin DA, Larson DW, Marcello PW, Posner MC, Read TE, Monson JRT, Wren SM, Pisters PWT, Nelson H (2019) Disease-free survival and local recurrence for laparoscopic resection compared with open resection of Stage II to III rectal cancer: follow-up results of the ACOSOG Z6051 Randomized Controlled Trial. Ann Surg 269:589–595

    Article  Google Scholar 

  10. Stevenson ARL, Solomon MJ, Brown CSB, Lumley JW, Hewett P, Clouston AD, Gebski VJ, Wilson K, Hague W, Simes J, Australasian Gastro-Intestinal Trials Group Ai (2019) Disease-free survival and local recurrence after laparoscopic-assisted resection or open resection for rectal cancer: the Australasian Laparoscopic Cancer of the Rectum Randomized Clinical Trial. Ann Surg 269:596–602

    Article  Google Scholar 

  11. van der Pas MH, Haglind E, Cuesta MA, Furst A, Lacy AM, Hop WC, Bonjer HJ (2013) Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol 14:210–218

    Article  Google Scholar 

  12. Fleshman J, Branda M, Sargent DJ, Boller AM, George V, Abbas M, Peters WR Jr, Maun D, Chang G, Herline A, Fichera A, Mutch M, Wexner S, Whiteford M, Marks J, Birnbaum E, Margolin D, Larson D, Marcello P, Posner M, Read T, Monson J, Wren SM, Pisters PW, Nelson H (2015) Effect of laparoscopic-assisted resection vs open resection of Stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 Randomized Clinical Trial. JAMA 314:1346–1355

    Article  CAS  Google Scholar 

  13. Kang SB, Park JW, Jeong SY, Nam BH, Choi HS, Kim DW, Lim SB, Lee TG, Kim DY, Kim JS, Chang HJ, Lee HS, Kim SY, Jung KH, Hong YS, Kim JH, Sohn DK, Kim DH, Oh JH (2010) Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol 11:637–645

    Article  Google Scholar 

  14. Sylla P, Rattner DW, Delgado S, Lacy AM (2010) NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance. Surg Endosc 24:1205–1210

    Article  Google Scholar 

  15. Heald RJ (2013) A new solution to some old problems: transanal TME. Tech Coloproctol 17:257–258

    Article  CAS  Google Scholar 

  16. Tuech JJ, Karoui M, Lelong B, De Chaisemartin C, Bridoux V, Manceau G, Delpero JR, Hanoun L, Michot F (2015) A step toward NOTES total mesorectal excision for rectal cancer: endoscopic transanal proctectomy. Ann Surg 261:228–233

    Article  Google Scholar 

  17. Zeng Z, Luo S, Chen J, Cai Y, Zhang X, Kang L (2019) Comparison of pathological outcomes after transanal versus laparoscopic total mesorectal excision: a prospective study using data from randomized control trial. Surg Endosc 34:3956–3962

    Article  Google Scholar 

  18. Chang TC, Kiu KT (2018) Transanal total mesorectal excision in lower rectal cancer: comparison of short-term outcomes with conventional laparoscopic total mesorectal excision. J Laparoendosc Adv Surg Tech A 28:365–369

    Article  Google Scholar 

  19. Chen CC, Lai YL, Jiang JK, Chu CH, Huang IP, Chen WS, Cheng AY, Yang SH (2016) Transanal total mesorectal excision versus laparoscopic surgery for rectal cancer receiving neoadjuvant chemoradiation: a matched case-control study. Ann Surg Oncol 23:1169–1176

    Article  Google Scholar 

  20. Lacy AM, Tasende MM, Delgado S, Fernandez-Hevia M, Jimenez M, De Lacy B, Castells A, Bravo R, Wexner SD, Heald RJ (2015) Transanal total mesorectal excision for rectal cancer: outcomes after 140 patients. J Am Coll Surg 221:415–423

    Article  Google Scholar 

  21. Kang L, Chen YG, Zhang H, Zhang HY, Lin GL, Yang YC, Chen WH, Luo SL, Chen N, Tong WD, Shen ZL, Xiong DH, Xiao Y, Zhang ZT, Wang JP (2020) Transanal total mesorectal excision for rectal cancer: a multicentric cohort study. Gastroenterol Rep 8:36–41

    Article  Google Scholar 

  22. Perdawood SK, Kroeigaard J, Eriksen M, Mortensen P (2020) Transanal total mesorectal excision: the Slagelse experience 2013–2019. Surg Endosc 35:826–836

    Article  Google Scholar 

  23. Hol JC, van Oostendorp SE, Tuynman JB, Sietses C (2019) Long-term oncological results after transanal total mesorectal excision for rectal carcinoma. Tech Coloproctol 23:903–911

    Article  Google Scholar 

  24. van Oostendorp SE, Belgers HJ, Bootsma BT, Hol JC, Belt E, Bleeker W, Den Boer FC, Demirkiran A, Dunker MS, Fabry HFJ, Graaf EJR, Knol JJ, Oosterling SJ, Slooter GD, Sonneveld DJA, Talsma AK, Van Westreenen HL, Kusters M, Hompes R, Bonjer HJ, Sietses C, Tuynman JB (2020) Locoregional recurrences after transanal total mesorectal excision of rectal cancer during implementation. Br J Surg 107:1211–1220

    Article  Google Scholar 

  25. Roodbeen SX, Spinelli A, Bemelman WA, Di Candido F, Cardepont M, Denost Q, D’Hoore A, Houben B, Knol JJ, Martín-Pérez B, Rullier E, Sands D, Setton I, Van de Steen K, Tanis PJ, Wexner SD, Hompes R, Wolthuis AM (2020) Local recurrence after transanal total mesorectal excision for rectal cancer. Ann Surg 274:359–366

    Article  Google Scholar 

  26. Larsen SG, Pfeffer F, Kørner H, Norwegian CCG, On BOTN (2019) Norwegian moratorium on transanal total mesorectal excision. Br J Surg 106:1120–1121

    Article  CAS  Google Scholar 

  27. Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th Edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17:1471–1474

    Article  Google Scholar 

  28. Paun BC, Cassie S, MacLean AR, Dixon E, Buie WD (2010) Postoperative complications following surgery for rectal cancer. Ann Surg 251:807–818

    Article  Google Scholar 

  29. Rahbari NN, Weitz J, Hohenberger W, Heald RJ, Moran B, Ulrich A, Holm T, Wong WD, Tiret E, Moriya Y, Laurberg S, den Dulk M, van de Velde C, Büchler MW (2010) Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer. Surgery 147:339–351

    Article  Google Scholar 

  30. Penna M, Hompes R, Arnold S, Wynn G, Austin R, Warusavitarne J, Moran B, Hanna GB, Mortensen NJ, Tekkis PP, International Ta TMERC (2018) Incidence and risk factors for anastomotic failure in 1594 patients treated by transanal total mesorectal excision: results from the International TaTME Registry. Ann Surg 269:700

    Article  Google Scholar 

  31. de’Angelis N, Portigliotti L, Azoulay D, Brunetti F (2015) Transanal total mesorectal excision for rectal cancer: a single center experience and systematic review of the literature. Langenbecks Arch Surg 400:945–959

    Article  Google Scholar 

  32. Stevenson AR, Solomon MJ, Lumley JW, Hewett P, Clouston AD, Gebski VJ, Davies L, Wilson K, Hague W, Simes J (2015) Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT Randomized Clinical Trial. JAMA 314:1356–1363

    Article  CAS  Google Scholar 

  33. de Lacy FB, van Laarhoven J, Pena R, Arroyave MC, Bravo R, Cuatrecasas M, Lacy AM (2018) Transanal total mesorectal excision: pathological results of 186 patients with mid and low rectal cancer. Surg Endosc 32:2442–2447

    Article  Google Scholar 

  34. Penna M, Hompes R, Arnold S, Wynn G, Austin R, Warusavitarne J, Moran B, Hanna GB, Mortensen NJ, Tekkis PP, Ta TMERC (2017) Transanal total mesorectal excision: International Registry results of the first 720 cases. Ann Surg 266:111–117

    Article  Google Scholar 

  35. Wasmuth HH, Faerden AE, Myklebust TA, Pfeffer F, Norderval S, Riis R, Olsen OC, Lambrecht JR, Korner H, Larsen SG, Forsmo HM, Baekkelund O, Lavik S, Knapp JC, Sjo O, Rashid G (2020) Transanal total mesorectal excision for rectal cancer has been suspended in Norway. Br J Surg 107:121–130

    Article  CAS  Google Scholar 

  36. Zeng Z, Liu Z, Huang L, Liu H, Jie H, Luo S, Zhang X, Kang L (2020) Transanal total mesorectal excision in mid-low rectal cancer: evaluation of the learning curve and comparison of short-term results with standard laparoscopic TME. Dis Colon Rectum 64:380–388

    Article  Google Scholar 

  37. Caycedo-Marulanda A, Brown CJ, Chadi SA, Ashamalla S, Lee L, Stotland P, Hameed U, Melich G, Ma G, Letarte F, Karimuddin A, Quereshy F, Phang T, Raval M, Vikis E, Liberman AS, Bouchard A, Bouchard P, Drolet S (2020) Canadian taTME expert collaboration (CaTaCO) position statement. Surg Endosc 34:3748–3753

    Article  Google Scholar 

Download references

Acknowledgements

We would like to thank Dr. Dyke, Dr. Kenneth, and Dr. Weiwei Shi for the scientific editing, and Zijun Huang and Yanping Liu for collecting some of the data.

Funding

This project was supported by grants from the Fundamental Research Funds for the Central Universities (Grant No. 16ykjc25 to Liang Kang) and Sun Yat-sen University Clinical Research 5010 Program (Grant No. 2016005 to Liang Kang).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Huashan Liu or Liang Kang.

Ethics declarations

Conflict of interest

Drs. Zeng, Liu, Liu, Luo, Liang, Huang, Ruan, Chen, Jie, Liang, and Kang have no conflicts of interest or financial ties to disclose. All authors are aware of and agree to the content of the paper and their being listed as an author of the paper.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zeng, Z., Liu, Z., Luo, S. et al. Three-year outcomes of transanal total mesorectal excision versus standard laparoscopic total mesorectal excision for mid and low rectal cancer. Surg Endosc 36, 3902–3910 (2022). https://doi.org/10.1007/s00464-021-08707-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-021-08707-4

Keywords

Navigation